{"id":"W2033817897","doi":"10.1111/ijcp.12194","title":"Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies","year":2013,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma","keywords":"Medicine; Mirabegron; Overactive bladder; Placebo; Tolterodine; Adverse effect; Urology; Internal medicine; Randomized controlled trial; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004423501,0.0002586621,0.002434205,0.0008616467,0.00009387386,0.00007383597,0.0003277141,0.0001345823,0.0001483078],"category_scores_gemma":[0.0160826,0.0001459913,0.002137012,0.0006697794,0.0003084471,0.0005437448,0.00006919279,0.0004478411,0.000003034571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000113334,"about_ca_system_score_gemma":0.0003379174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002030461,"about_ca_topic_score_gemma":0.00006760148,"domain_scores_codex":[0.9947007,0.0006402182,0.002917864,0.0003262277,0.001173249,0.0002417063],"domain_scores_gemma":[0.9126321,0.07911798,0.003090442,0.0003328416,0.004592089,0.0002345333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.617905,0.006640485,0.002254192,0.00001952901,0.3396532,0.00006625016,0.00153993,0.0006936545,0.0004397693,0.00006889525,0.0003465418,0.03037254],"study_design_scores_gemma":[0.765482,0.009650469,0.03355904,0.00008144238,0.1620283,0.00009220775,0.004424141,0.01425026,0.001378629,0.0002298334,0.008705952,0.0001177467],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750856,0.007451064,0.005524226,0.007419605,0.0003428,0.003100043,0.0000855406,0.000006971211,0.000984143],"genre_scores_gemma":[0.9769666,0.02020331,0.001391963,0.0001671727,0.000530887,0.0001070368,0.0000323975,0.00001790058,0.0005827219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1776249,"threshold_uncertainty_score":0.9922054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1390892319473524,"score_gpt":0.4997503020052501,"score_spread":0.3606610700578977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}